Waters Corporation EBITDA

EBITDA of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA growth rates and interactive chart. Earnings before interest, tax, depreciation and amortization (EBITDA) is a measure of a company's operating performance. Essentially, it's a way to evaluate a company's performance without having to factor in depreciation, interest expenses (debt), writedowns or other accounting measures and taxes. EBITDA, however, can be misleading because it strips out the cost of capital investments like property, plant, and equipment. To calculate EBITDA, take operating profit (also called EBIT) and add back depreciation and amortization.


Highlights and Quick Summary

  • EBITDA for the quarter ending December 30, 2020 was $298 Million (a 57.44% increase compared to previous quarter)
  • Year-over-year quarterly EBITDA increased by 205.72%
  • Annual EBITDA for 2020 was $771 Million (a -5.27% decrease from previous year)
  • Annual EBITDA for 2019 was $814 Million (a -4.06% decrease from previous year)
  • Annual EBITDA for 2018 was $848 Million (a 10.41% increase from previous year)
  • Twelve month EBITDA ending December 30, 2020 was $771 Million (a 4.98% increase compared to previous quarter)
  • Twelve month trailing EBITDA increased by 0.72% year-over-year
Trailing EBITDA for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
$771 Million $734 Million $745 Million $765 Million
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA of Waters Corporation

Most recent EBITDAof WAT including historical data for past 10 years.

Interactive Chart of EBITDA of Waters Corporation

Waters Corporation EBITDA for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $297.98 $189.27 $186.13 $97.47 $770.85
2019 $261.39 $199.94 $206.51 $145.92 $813.75
2018 $270.13 $198.65 $206.39 $173.02 $848.18
2017 $258.33 $184.87 $183.34 $141.67 $768.2
2016 $233.12 $176.02 $176.26 $136.09 $721.49
2015 $204.4 $157.6 $152.91 $142.53 $657.44
2014 $195.72 $168.14 $139.18 $109.1 $612.14
2013 $197.62 $139.64 $132.11 $127.67 $597.04
2012 $177.01 $142.37 $136.16 $124.79 $580.32
2011 $181.22 $143.86 $137.85 $132.06 $594.99
2010 $165.22 $119.05 $120.89 $512.49

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.